1-Methyl-4-[4-(propan-2-yl)phenoxy]benzene | 61343-81-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-Methyl-4-[4-(propan-2-yl)phenoxy]benzene
• 英文别名: 1-methyl-4-(4-propan-2-ylphenoxy)benzene
• CAS: 61343-81-5
• 化学式: C₁₆H₁₈O
• 分子量: 226.31
• InChiKey: OABXGSVUPMIMMX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• PHOTOLYTIC ACID-GENERATING POLYMERS AND MONOMERS FOR THEIR CONSTRUCTION
  申请人：BRAINARD Robert L.

  公开号：US20110130538A1

  公开（公告）日：2011-06-02

  Polymers for photoresists and monomers for incorporation into those polymers are disclosed. The polymers comprise a photoacid generator (PAG) component and at least a second component that is photolytically stable and acid-stable. The polymers may also contain a third, acid-labile component. The photoacid generator is based on N-sulfoxyimides and related moieties that contain photolabile oxygen-heteroatom and oxygen-aromatic carbon bonds.

  本发明揭示了用于光刻胶的聚合物和用于纳入这些聚合物的单体。聚合物包括光酸发生器（PAG）组分和至少第二个组分，该组分具有光解稳定性和酸稳定性。聚合物还可以包含第三种酸不稳定的组分。光酸发生器基于N-磺酰氧亚胺和相关的含有光敏氧杂原子和氧芳香碳键的基团。
• PHOSPHAPHENANTHRENE COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME
  申请人：Chung Kwang Choon

  公开号：US20100252818A1

  公开（公告）日：2010-10-07

  The present invention relates to new phosphaphenanthrene compounds with excellent light emitting property and an organic light emitting diode (OLED) using the same.

  本发明涉及具有优异的发光性质的新型磷代菲化合物及其所使用的有机发光二极管（OLED）。
• PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS
  申请人：Allen David George

  公开号：US20090326003A1

  公开（公告）日：2009-12-31

  The present invention provides a compound of formula (I) or a salt thereof (in particular, a pharmaceutically acceptable salt thereof): The invention also provides the use of the compounds or salts as inhibitors of phosphodiesterase type IV (PDE4) for the treatment or prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis, atopic dermatitis or psoriasis, e.g. in a mammal such as a human.

  本发明提供了式（I）的化合物或其盐（特别是其药学上可接受的盐）：本发明还提供了将该化合物或盐用作磷酸二酯酶IV（PDE4）的抑制剂，用于治疗或预防炎症或过敏性疾病，如慢性阻塞性肺疾病（COPD），哮喘，鼻炎，特应性皮炎或银屑病，例如在哺乳动物，如人类中。
• Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
  申请人：Zhu Yun-Fei

  公开号：US20070208049A1

  公开（公告）日：2007-09-06

  GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein A, Q, R 1 , R 2 , R 3a , R 3b , R 4 , R 5 , R 6 and n are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

  本发明揭示了GnRH受体拮抗剂，其在治疗男女性激素相关疾病方面具有用途。本发明的化合物具有以下结构：其中A、Q、R1、R2、R3a、R3b、R4、R5、R6和n的定义如本文所述，包括立体异构体、前药和其药学上可接受的盐。本发明还揭示了含有本发明化合物与药学上可接受的载体组合的组合物，以及与其相关的方法，用于在需要时对抗促性腺激素释放激素。
• HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES
  申请人：Zhi Lin

  公开号：US20120295904A1

  公开（公告）日：2012-11-22

  The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.

  本实施例涉及具有生理效应的化合物，例如激活造血生长因子受体。本实施例还涉及使用这些化合物来治疗各种状况、疾病和疾病，例如造血系统状况和疾病。